Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Effectiveness of Yoga and Combined Exercise in Rheumatoid Arthritis [NA]
The completed trial evaluates the effectiveness of yoga and a combined exercise program for individuals with rheumatoid arthritis.
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: RA-PRO PRAGMATIC TRIAL [Phase 3]
Phase 3 clinical trial RA-PRO PRAGMATIC for rheumatoid arthritis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection [EARLY_Phase 1]
Clinical trial update announcing an early Phase 1 study of UTAA91 injection for refractory rheumatoid arthritis, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: A Study of Baricitinib in Participants With Rheumatoid Arthritis [Phase 4]
A Phase 4 study evaluating baricitinib in participants with rheumatoid arthritis has completed.
-
EMA approval · 2025-07-17EMA Authorised: Nordimet (methotrexate) — Nordic Group B.V.
EMA authorised Nordimet (methotrexate) by Nordic Group B.V. for use in arthritis-related conditions including rheumatoid arthritis, psoriati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: This Study Aims to Characterize and Compare Patients of Adult-onset RA With Patients of Elderly-onset RA Based on the Clinical Manifestations, Disease Activity, Severity Parameters, and Therapeutic Features
A clinical trial update describing an effort to characterize and compare adult-onset rheumatoid arthritis with elderly-onset rheumatoid arth…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating metformin as an adjunct to conventional therapy for rheumatoid arthritis.
-
EMA approval · 2025-07-14EMA Authorised: Ruxience (rituximab) — Pfizer Europe MA EEIG
The EMA authorised Ruxience, a rituximab biosimilar by Pfizer Europe MA EEIG, for several indications including chronic lymphocytic leukemia…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Artificial Intelligence Literacy and E-Health Literacy in Rheumatic Diseases
A completed clinical trial evaluating artificial intelligence literacy and e-health literacy in people with rheumatic diseases, including rh…
-
CLINICAL_TRIALS withdrawal · 2025-07-14Clinical Trial Update: The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating paroxetine as a GRK2 inhibitor adjunct to conventional therapy for rheumatoid arthritis has been withd…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating YTS109 cell therapy for relapsed/refractory autoimmune diseases is currently recruiting. The study cover…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis [Phase 2]
Phase 2 study evaluating the efficacy and safety of SAR441566 in adults with rheumatoid arthritis has completed.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Rheumatoid Arthritis and Osteosarcopenia: Associated Factors
A clinical trial from Konya Beyhekim Training and Research Hospital is investigating factors associated with osteosarcopenia in patients wit…
-
EMA approval · 2025-07-09EMA Authorised: Ituxredi (rituximab) — Reddy Holding GmbH
The EMA authorised Ituxredi (rituximab) by Reddy Holding GmbH. It is indicated for non-Hodgkin lymphoma, chronic lymphocytic leukemia, and r…
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis [Phase 2]
Phase II trial of VDJ001 in patients with moderate-to-severe active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis [Phase 1]
Phase 1 clinical trial update for CLN-978, a subcutaneously administered CD19-directed T cell engager, being studied in rheumatoid arthritis…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Personalized Outreach for Equitable Treatment in Rheumatology [NA]
A University of British Columbia–sponsored clinical trial aimed at personalized outreach for equitable treatment in rheumatic diseases, curr…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis [Phase 3]
Phase 3 long-term extension study evaluating the safety and efficacy of filgotinib in adults with rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Golimumab Safety and Surveillance Program Using the Ingenix NHI Database
This document reports the completion of a safety surveillance trial for golimumab using the Ingenix NHI database to monitor safety in rheuma…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: G7 BiSpherical Acetabular Shell PMCF Study
ClinicalTrials.gov update for Zimmer Biomet's G7 BiSpherical Acetabular Shell PMCF study, currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: The Effect of Non-Surgical Periodontal Therapy on Rheumatoid Arthritis [NA]
A completed clinical trial evaluating whether non-surgical periodontal therapy impacts rheumatoid arthritis outcomes.
-
EMA approval · 2025-06-24EMA Authorised: Zessly (infliximab) — Sandoz GmbH
EMA authorised Zessly (infliximab) from Sandoz GmbH as a biosimilar for treatment of several inflammatory diseases, including rheumatoid art…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes
A University of Florida-sponsored clinical trial is recruiting to examine pain processing in inflammatory and non-inflammatory chronic pain …
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Care: A Randomized Controlled Trial [NA]
A randomized trial evaluating whether primary care providers trained in rheumatoid arthritis management can provide comparable care to rheum…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings
A completed clinical trial update assessing the long-term outcomes of abatacept in biologic treatment-naive rheumatoid arthritis patients in…